Improved risk-benefit ratio for topical triamcinolone acetonide in TransfersomeR in comparison with equipotent cream and ointment: a randomized controlled trial

Abstract

Transfersome may significantly improve the risk-benefit ratio of topically applied glucocorticosteroids.